NCT02077920 - Methods of Chlorhexidine Cleansing to Prevent Ventilator-Associated Pneumonia (VAP) | Biotech Hunter

Enrollment

192

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2019

Study Completion Date

August 31, 2019

Conditions

Ventilator-associated Pneumonia

Interventions

DRUG

Chlorhexidine

"SFDA Approval No. H21020748; Jinzhou Jiu Tai Pharmaceutical Co., Ltd., Liaoning, China~Drug administration and preparation:~* Drug administration: oropharyngeal rinsing and suctioning of subglottic secretions~* Drug preparation: 0.12% chlorhexidine solution prepared with distilled water that has been sterilized by autoclaving"

DRUG

0.9% sodium chloride injection

SFDA Approval No. H20045252; Shenyang Zhiying Pharmaceutical Co., Ltd., Liaoning, China

DEVICE

Endotracheal tube

Type 5-10115; size 7.0 mm, 7.5 mm, or 8.0 mm; purchased from Teleflex Medical (USA).

DEVICE

Fiber bronchoscope

For suctioning of subglottic secretions. BF-P30 (Olympus, Japan); BF-1T20 (Olympus, Japan); or FB-18BS (Pentax, Japan).

Trial Locations (1)

110000

The General Hospital of Shenyang Military Region, Shenyang

All Listed Sponsors

lead

General Hospital of Shenyang Military Region

OTHER